Privia Health Group (NASDAQ:PRVA) Reaches New 1-Year High – What’s Next?

Privia Health Group, Inc. (NASDAQ:PRVA)’s share price hit a new 52-week high on Tuesday . The stock traded as high as $25.49 and last traded at $25.47, with a volume of 764095 shares traded. The stock had previously closed at $24.87.

Analysts Set New Price Targets

PRVA has been the subject of several recent research reports. Macquarie began coverage on Privia Health Group in a report on Monday, December 16th. They set an “outperform” rating and a $25.00 price target for the company. Needham & Company LLC started coverage on shares of Privia Health Group in a research note on Friday, January 10th. They set a “buy” rating and a $25.00 target price on the stock. JMP Securities reiterated a “market outperform” rating and issued a $26.00 price target on shares of Privia Health Group in a research note on Friday, February 14th. JPMorgan Chase & Co. boosted their price objective on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Finally, Truist Financial raised their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Two analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Privia Health Group presently has a consensus rating of “Buy” and a consensus target price of $24.94.

Privia Health Group Stock Performance

The firm has a market cap of $2.96 billion, a P/E ratio of 246.42, a price-to-earnings-growth ratio of 3.53 and a beta of 0.87. The firm’s fifty day moving average price is $21.85 and its 200 day moving average price is $20.33.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. First Horizon Advisors Inc. boosted its position in Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after purchasing an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in shares of Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after buying an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. bought a new position in shares of Privia Health Group during the 4th quarter worth approximately $51,000. Quarry LP lifted its position in Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after acquiring an additional 2,533 shares during the last quarter. Finally, KBC Group NV boosted its stake in Privia Health Group by 34.6% in the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after acquiring an additional 871 shares in the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.